BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32832872)

  • 1. Discovery of a First-in-Class Potent Small Molecule Antagonist against the Adrenomedullin-2 Receptor.
    Avgoustou P; Jailani ABA; Zirimwabagabo JO; Tozer MJ; Gibson KR; Glossop PA; Mills JEJ; Porter RA; Blaney P; Bungay PJ; Wang N; Shaw AP; Bigos KJA; Holmes JL; Warrington JI; Skerry TM; Harrity JPA; Richards GO
    ACS Pharmacol Transl Sci; 2020 Aug; 3(4):706-719. PubMed ID: 32832872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.
    Zirimwabagabo JO; Jailani ABA; Avgoustou P; Tozer MJ; Gibson KR; Glossop PA; Mills JEJ; Porter RA; Blaney P; Wang N; Skerry TM; Richards GO; Harrity JPA
    J Med Chem; 2021 Mar; 64(6):3299-3319. PubMed ID: 33666424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
    Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
    Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
    Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
    Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
    Moad HE; Pioszak AA
    Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of components of the cardiomyocyte adrenomedullin/intermedin receptor system following blood pressure reduction in nitric oxide-deficient hypertension.
    Zhao Y; Bell D; Smith LR; Zhao L; Devine AB; McHenry EM; Nicholls DP; McDermott BJ
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1269-81. PubMed ID: 16326922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand-induced internalization, recycling, and resensitization of adrenomedullin receptors depend not on CLR or RAMP alone but on the receptor complex as a whole.
    Nag K; Sultana N; Kato A; Dranik A; Nakamura N; Kutsuzawa K; Hirose S; Akaike T
    Gen Comp Endocrinol; 2015 Feb; 212():156-62. PubMed ID: 24815888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function analysis of amino acid 74 of human RAMP1 and RAMP3 and its role in peptide interactions with adrenomedullin and calcitonin gene-related peptide receptors.
    Qi T; Ly K; Poyner DR; Christopoulos G; Sexton PM; Hay DL
    Peptides; 2011 May; 32(5):1060-7. PubMed ID: 21402116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cardiovascular development and homeostasis by the adrenomedullin-RAMP system.
    Shindo T; Tanaka M; Kamiyoshi A; Ichikawa-Shindo Y; Kawate H; Yamauchi A; Sakurai T
    Peptides; 2019 Jan; 111():55-61. PubMed ID: 29689347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
    Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
    Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The third extracellular loop of the human calcitonin receptor-like receptor is crucial for the activation of adrenomedullin signalling.
    Kuwasako K; Hay DL; Nagata S; Hikosaka T; Kitamura K; Kato J
    Br J Pharmacol; 2012 May; 166(1):137-50. PubMed ID: 22142144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor activity-modifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age.
    Dackor R; Fritz-Six K; Smithies O; Caron K
    J Biol Chem; 2007 Jun; 282(25):18094-18099. PubMed ID: 17470425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo.
    Nouguerède E; Berenguer C; Garcia S; Bennani B; Delfino C; Nanni I; Dahan L; Gasmi M; Seitz JF; Martin PM; Ouafik L
    Cancer Med; 2013 Apr; 2(2):196-207. PubMed ID: 23634287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the CGRP Family of Neuropeptides and their Receptors in the Trigeminal Ganglion.
    Edvinsson L; Grell AS; Warfvinge K
    J Mol Neurosci; 2020 Jun; 70(6):930-944. PubMed ID: 32086679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared and separate functions of the RAMP-based adrenomedullin receptors.
    Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
    Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.
    Hay DL; Howitt SG; Conner AC; Schindler M; Smith DM; Poyner DR
    Br J Pharmacol; 2003 Oct; 140(3):477-86. PubMed ID: 12970090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization.
    Kuwasako K; Kitamura K; Nagata S; Nozaki N; Kato J
    Biochem Biophys Res Commun; 2012 Apr; 420(3):582-7. PubMed ID: 22445753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the expression of calcitonin receptor-like receptor, receptor activity-modifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatments.
    Thota C; Gangula PR; Dong YL; Yallampalli C
    Biol Reprod; 2003 Oct; 69(4):1432-7. PubMed ID: 12801991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function.
    Qi T; Christopoulos G; Bailey RJ; Christopoulos A; Sexton PM; Hay DL
    Mol Pharmacol; 2008 Oct; 74(4):1059-71. PubMed ID: 18593822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Picomolar Affinity Antagonist and Sustained Signaling Agonist Peptide Ligands for the Adrenomedullin and Calcitonin Gene-Related Peptide Receptors.
    Booe JM; Warner ML; Pioszak AA
    ACS Pharmacol Transl Sci; 2020 Aug; 3(4):759-772. PubMed ID: 32832875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.